Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | CASP3 | P42574 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.32 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.32 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25513692 | 0.89 | — | — | |
| SCHEMBL25513547 | 0.89 | — | — | |
| SCHEMBL25513912 | 0.81 | NPC1 (0.31) | NPC1ALDH1A1HPGDCASP3RAB9A | |
| SCHEMBL25512036 | 0.76 | NPC1 (0.32) | NPC1ALDH1A1HPGDCASP3RAB9A | |
| SCHEMBL25512593 | 0.76 | CNR1 (0.32) | NPC1ALDH1A1HPGDCASP3RAB9A | |
| SCHEMBL25512702 | 0.76 | ALDH1A1 (0.32) | NPC1ALDH1A1HPGDCASP3RAB9A | |
| SCHEMBL25513757 | 0.74 | LPL (0.34) | — | |
| SCHEMBL25512181 | 0.73 | NPC1 (0.30) | NPC1ALDH1A1HPGDCASP3RAB9A | |
| SCHEMBL25512402 | 0.73 | CNR1 (0.31) | NPC1ALDH1A1HPGDCASP3RAB9A | |
| SCHEMBL25513279 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230159567-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159567-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | OR10J3, OXER1, OXSR1 | NPC1 3250/4885ALDH1A1 2779/4885HPGD 3270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.